-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Influenza-virus-IN-1
![{PARAM:[Name]}({[CAS]})](https://resource.bocsci.com/structure/108729-21-1.gif)
| Category | Influenza Virus |
| CAS | 108729-21-1 |
| Description | Influenza virus-IN-1 (compound 14) is a potent influenza A virus inhibitor with an EC50 of 2.46 µM and CC50 of >200 µM. Influenza virus-IN-1 shows a concentration dependent inhibition activity for PAN endonuclease with EC50 of 312.36 nM. Influenza virus-IN-1 shows shows anti-influenza A virus activities. |
Product Information
| Synonyms | Influenza virus-IN-1|SCHEMBL109104|CHEMBL4748299|HY-143492|CS-0459554|N-[2-(3,4-Dihydroxyphenyl)ethyl]-2-(3,4-dihydroxyphenyl)acetamide |
| Molecular Weight | 303.31 |
| Molecular Formula | C16H17NO5 |
| Canonical SMILES | C1=CC(=C(C=C1CCNC(=O)CC2=CC(=C(C=C2)O)O)O)O |
| Purity | ≥98% (HPLC) |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 364 |
| Exact Mass | 303.11067264 |
| Target | EC50: 2.46 µM (influenza virus); CC50: >200 µM (influenza virus) |
| XLogP3-AA | 1.7 |